QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text Full Text (PDF) All Versions of this Article: jpet.103.060806v1 309/2/845    most recent Submit a response Alert me when this article is cited Alert me when eLetters are posted Alert me if a correction is posted Citation Map Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Ni, W. Articles by Watts, S. W. Search for Related Content PubMed PubMed Citation Articles by Ni, W. Articles by Watts, S. W.

CARDIOVASCULAR

The Fenfluramine Metabolite (+)-Norfenfluramine Is Vasoactive

Department of Pharmacology and Toxicology, Michigan State University, East Lansing, Michigan

The anorexigen (+)-fenfluramine was used for treatment of obesity until the association of use with valvular heart disease and primary pulmonary hypertension. (+)-Fenfluramine has been found in Chinese and Korean slimming pills. The hepatic metabolite of (+)-fenfluramine, (+)-norfenfluramine, has affinity for 5-hydroxytryptamine (5-HT)_2A and 5-HT_2B receptors. We tested the hypothesis that (+)-norfenfluramine contracts arterial smooth muscle in a 5-HT receptor-dependent manner and acts as a pressor in the conscious rat. Isometric contraction experiments showed that (+)-norfenfluramine (10 nM, 100 µM) but not (+)-fenfluramine nor the isomer (-)-norfenfluramine caused concentration-dependent contraction in arteries [-log EC₅₀ (moles per liter), thoracic aorta = 5.77 ± 0.09; renal artery = 6.29 ± 0.02; mesenteric resistance artery = 5.70 ± 0.06]. Contraction was dependent on the 5-HT_2A receptor because ketanserin (10 nM) rightward shifted (+)-norfenfluramine response curves (aorta = 16-fold, renal artery = 26-fold, and resistance artery = >100-fold). Dependence on activation of 5-HT_2A receptors and independence of (+)-norfenfluramine-induced contraction from stimulation of -adrenergic receptors and the sympathetic nervous system was validated by demonstrating 1) unchanged contraction to (+)-norfenfluramine in arteries from chemically denervated rats; 2) a minimal effect of the ₁-adrenergic receptor antagonist prazosin (100 nM) on contraction; and 3) antagonism by [6-methyl-l-(1-methylethy)ergoline-8-carboxylic acid 2-hydroxy-1 methylpropyl ester maleate] LY53857 [6-methyl-1-(1-methylethy)-ergoline-8-carboxylic acid 2-hydroxy-1 methylpropyl ester maleate], a 5-HT₂ receptor antagonist without -receptor affinity. (+)-Norfenfluramine (10-300 µg/kg i.v.) caused a dose-dependent increase in mean arterial blood pressure in conscious rats, the maximum of which could be virtually abolished by ketanserin (3 mg/kg i.v.) but not prazosin (0.2 mg/kg i.v.). Our findings demonstrate for the first time that (+)-norfenfluramine is vasoactive and has the potential to increase blood pressure.

Address correspondence to: Wei Ni, Department of Pharmacology and Toxicology, B445 Life Sciences Bldg., Michigan State University, East Lansing, MI 48824-1317. E-mail: niwei{at}msu.edu

This article has been cited by other articles:

				S. W. Watts The love of a lifetime: 5-HT in the cardiovascular system Am J Physiol Regulatory Integrative Comp Physiol, February 1, 2009; 296(2): R252 - R256. [Abstract] [Full Text] [PDF]

				W. Ni, G. D. Fink, and S. W. Watts The 5-Hydroxytryptamine2A Receptor Is Involved in (+)-Norfenfluramine-Induced Arterial Contraction and Blood Pressure Increase in Deoxycorticosterone Acetate-Salt Hypertension J. Pharmacol. Exp. Ther., May 1, 2007; 321(2): 485 - 491. [Abstract] [Full Text] [PDF]

				W. Ni, C. S. Wilhelm, M. Bader, D. L. Murphy, K. Lookingland, and S. W. Watts (+)-Norfenfluramine-Induced Arterial Contraction Is Not Dependent on Endogenous 5-Hydroxytryptamine or 5-Hydroxytryptamine Transporter J. Pharmacol. Exp. Ther., September 1, 2005; 314(3): 953 - 960. [Abstract] [Full Text] [PDF]